143
Views
4
CrossRef citations to date
0
Altmetric
Original Article

Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers

, , &
Pages 821-831 | Received 29 Dec 2014, Accepted 27 Feb 2015, Published online: 01 Apr 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fengling Wang, Lian Li, Wei Sun, Lijia Li, Yuanyuan Liu, Yuan Huang & Zhou Zhou. (2018) A novel αVβ3 ligand-modified HPMA copolymers for anticancer drug delivery. Journal of Drug Targeting 26:3, pages 231-241.
Read now

Articles from other publishers (3)

Yuanyuan Liu, Zhou Zhou, Xi Lin, Xiaofeng Xiong, Rui Zhou, Minglu Zhou & Yuan Huang. (2019) Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance. Biomacromolecules 20:10, pages 3755-3766.
Crossref
Zhou Zhou, YanXi Liu, Lei Wu, Lian Li & Yuan Huang. (2017) Enhanced nuclear delivery of anti-cancer drugs using micelles containing releasable membrane fusion peptide and nuclear-targeting retinoic acid. Journal of Materials Chemistry B 5:34, pages 7175-7185.
Crossref
Qingqing Yang, Lei Wu, Lian Li, Zhou Zhou & Yuan Huang. (2017) Subcellular co-delivery of two different site-oriented payloads for tumor therapy. Nanoscale 9:4, pages 1547-1558.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.